General Head and Neck Cancer


Twice-daily radiation therapy reduces mortality from head and neck cancer (February 14, 2017)

Treating head and neck cancer patients with a twice-daily radiation therapy schedule combined with chemotherapy could save more lives, according to new research presented at the European Cancer Congress... Continue Reading

Opdivo Approved for Advanced Head and Neck Cancer (November 28, 2016)

The United States Food and Drug Administration (FDA) has approved the immunotherapeutic agent, Opdivo® (nivolumab) for the treatment of advanced head and neck cancer. Specifically,  the indication is... Continue Reading

Head and Neck Cancer- Your Questions Answered (October 17, 2016)

CancerConnect and The Ohio State University Comprehensive Cancer Center- James Cancer Hospital and Solove Research Institute Present: Ask the Expert with Dr. Kang CancerConnect in collaboration with The... Continue Reading

Particular HPV Strain Linked to Improved Prognosis for Throat Cancer (October 17, 2016)

When it comes to cancer-causing viruses like human papillomavirus, or HPV, researchers are continuing to find that infection with one strain may be better than another. In an analysis of survival data... Continue Reading

Ask the Head and Neck Cancer Expert- Q&A Now Available! (October 14, 2016)

CancerConnect and The Ohio State University Comprehensive Cancer Center- James Cancer Hospital and Solove Research Institute Will Present: Ask the Expert with Dr. Kang CancerConnect in collaboration with... Continue Reading

PET/CT Combined More Effective Than MRI in Monitoring Head and Neck Cancer Patients’ Response to Treatment (October 5, 2016)

According to a recent study, combining PET/CT to monitor response to treatment in head and neck cancer patients appears more effective than MRI. Using PET/CT may better inform doctors whether treatment... Continue Reading

Announcing the CancerConnect Head and Neck Cancer Support Community (September 14, 2016)

Your story matters. Head and neck cancer is a challenging diagnosis, connecting with others who have had to deal with the side effects of treatment and the challenges of treatment decision making is an... Continue Reading

Head and Neck Cancer Immunotherapy Study with AXAL Advances to Second Stage (August 29, 2016)

Advaxis, Inc. (ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, today announced that its Phase 2 “window of opportunity” clinical study of its lead immunotherapy candidate,... Continue Reading

Keytruda® Approved for Advanced Head and Neck Cancer (August 24, 2016)

The United States Food and Drug Administration (FDA) has approved Keytruda® (pembrolizumab) for the treatment of advanced head and neck cancer that has stopped responding to platinum-based chemotherapy... Continue Reading

Compliance with Radiation Schedules Improves Survival in Head and Neck Cancer (June 9, 2016)

Patients with head and neck cancer who comply with their scheduled radiation treatments have significantly improved outcomes compared to those who miss 2 or more of their appointments within the prescribed... Continue Reading

Long-Lasting Responses Achieved with Keytruda® in Advanced Head and Neck Cancer (June 8, 2016)

Treatment with the immune-stimulating agent, Keytruda® (pembrolizumab), provides impressive long-term outcomes for some patients with metastatic or recurrent head and neck cancer. These results were recently... Continue Reading

Follow-Up Scans Reduce Need for Some Invasive Surgeries in Head and Neck Cancer (June 6, 2016)

Utilizing PET-CT scans following treatment for patients with head and neck cancer that has spread to their lymph nodes significantly reduces the need for invasive follow-up surgery. These results were... Continue Reading

More Evidence that PD-1 Inhibitors Improve Survival in Head and Neck Cancer (May 25, 2016)

Results from a recent large trial indicate that treatment with the immunotherapy agent Opdivo® (nivolumab) nearly doubles the survival rate at one year in patients with advanced head and neck squamous... Continue Reading

Addition of Chemotherapy Improves Survival in Some Elderly Patients with Head and Neck Cancer (May 12, 2016)

The addition of chemotherapy to radiation therapy (chemoradiation) improves survival among a subset of elderly patients with advanced head and neck cancer.  These results were recently presented at the... Continue Reading

Getting Your Head Around the Human Papillomavirus (May 1, 2016)

You may have heard about HPV’s role in cervical cancer, but what about head and neck cancer? By Kari Bohlke, ScD The human papillomavirus (HPV) has been in the news a great deal lately, but how much... Continue Reading

Another Reason to Break the Habit: Smoking Alters Bacterial Balance in Mouth (April 12, 2016)

Smoking drastically alters the oral microbiome, the mix of roughly 600 bacterial species that live in people’s mouths. This is the finding of a study led by NYU Langone Medical Center and its Laura... Continue Reading

Spring into Action: Help Share Oral, Head, and Neck Cancer Awareness Week, April 10-16 (April 4, 2016)

As the month of April brings oral, head, and neck cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment... Continue Reading

Better Outcomes in Oral Cancer with Surgery to Remove Lymph Nodes in Neck before Cancer Spreads (June 30, 2015)

In early squamous-cell oral cancer, surgery to remove lymph nodes in the neck before cancer spreads may result in better outcomes. These findings were presented at 2015 Annual Meeting of the American Society... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS